PBS update provides new options for people with CVD and leukaemia The latest changes also mean fluoxetine will no longer be subsidised from the start of 2021.
An antidepressant is now one of Australia’s most commonly prescribed drugs – but why? Nuance is necessary to interpret why prescriptions of sertraline have gone up, according to an expert.
‘Black Summer’ caused almost $2 billion in smoke-related health costs GPs will play a vital role in preparing their patients for this new bushfire season, experts say.
Tackling mild mental health concerns with short, sharp interventions Not all mental health consultations require referral or medication, experts said in a recent GP20 presentation.
People with cancer not making advance care plans with their GP A new survey suggests less than 3% discuss end-of-life care with their doctor.
What does a new Oxford COVID vaccine trial mean for Australia? The decision comes after doubts emerged over recent trial results that showed greater efficacy with a lower dosage.
Isolation led to loss of function for people with dementia: Report And those functions are unlikely to be restored.
Stigma limiting hepatitis C treatment Uptake has slowed despite Australians having access to highly effective treatment.
Surprise Oxford vaccine results due to manufacturing error Eyebrows were raised when trials showed volunteers who received a lower dose were better protected against COVID-19.
Framework for GPs to manage ‘long COVID’ A recent GP20 presentation examines how GPs can recognise the signs and manage an emerging clinical concern.